Can I Take Berberine with Egrifta (Tesamorelin)?
A clinical review of the berberine-tesamorelin interaction: pharmacokinetics, blood glucose effects, CYP3A4 concerns, and practical guidance for patients on Egrifta.
Tesamorelin and Supplements
16 source-based articles maintained by the HealthRX.com Editorial Team.
16articles
2topic areas covered
Jan 28, 2025latest review
Tesamorelin and Supplements library
Showing 16 of 16 clinical reviews.
Can I Take Calcium with Egrifta (Tesamorelin)?
What is known and not established about combining calcium supplements with Egrifta SV (tesamorelin) in HIV-associated lipodystrophy, including bone and IGF-1 considerations, and where a pharmacist should be consulted before dosing decisions.
Can I Take CoQ10 with Egrifta (Tesamorelin)?
A guide to combining CoQ10 with Egrifta (tesamorelin): interaction mechanism, safety data, dosing timing, and monitoring recommendations for people on HIV-associated lipodystrophy therapy.
Can I Take Creatine with Egrifta (Tesamorelin)?
A guide to combining creatine supplementation with tesamorelin (Egrifta), covering the creatinine-elevation concern, renal monitoring, pharmacokinetics, and practical dosing guidance.
Can I Take Ginseng with Egrifta (Tesamorelin)?
Evidence-based guide on combining ginseng supplements with tesamorelin (Egrifta), covering interaction mechanisms, glucose effects, monitoring, and dose-separation strategies.
Can I Take Glycine with Egrifta (Tesamorelin)?
A clinical review of glycine and tesamorelin (Egrifta) co-administration: mechanisms, interaction type, glycemic monitoring, dosing timing, and when to contact your prescriber.
Can I Take Green Tea Extract (EGCG) with Egrifta (Tesamorelin)?
A guide covering the hepatotoxicity risk, CYP enzyme interactions, and monitoring considerations when combining green tea extract or EGCG with Egrifta (tesamorelin) for HIV-associated lipodystrophy.
Can I Take Lion's Mane with Egrifta (Tesamorelin)?
A guide to combining lion's mane mushroom with tesamorelin (Egrifta), covering pharmacokinetic and pharmacodynamic interaction risks, NGF signaling overlap, bleeding considerations, and monitoring steps.
Can I Take Magnesium with Egrifta (Tesamorelin)?
A board-reviewed guide to the magnesium, tesamorelin interaction: mechanism, safety evidence, monitoring parameters, and practical dosing guidance for HIV-associated lipodystrophy patients.
Can I Take Melatonin with Egrifta (Tesamorelin)?
What is established, what is plausible, and what is unproven about combining melatonin with tesamorelin (Egrifta) for HIV-associated lipodystrophy, including the glucose-related pharmacodynamic concern and a verification checklist for clinicians and pharmacists.
Can I Take NAC (N-Acetylcysteine) with Egrifta (Tesamorelin)?
A guide to combining NAC with tesamorelin (Egrifta): mechanism-based interaction analysis, pharmacokinetic vs pharmacodynamic considerations, dosing timing, monitoring parameters, and clinical decision guidance.
Can I Take Reishi Mushroom with Egrifta (Tesamorelin)?
A guide to the reishi mushroom and tesamorelin interaction: mechanism, immune modulation, anticoagulant risk, monitoring, and practical guidance for people on Egrifta.
Can I Take Turmeric / Curcumin with Egrifta (Tesamorelin)?
A clinical guide to the turmeric/curcumin and tesamorelin interaction: mechanism, safety evidence, dosing considerations, and monitoring recommendations for patients on Egrifta.
Can I Take Vitamin B6 with Egrifta (Tesamorelin)?
A board-reviewed clinical guide on combining vitamin B6 with Egrifta (tesamorelin): interaction mechanisms, safe dose ranges, monitoring requirements, and when to call your prescriber.
Can I Take Vitamin D with Egrifta (Tesamorelin)?
A guide on combining vitamin D supplementation with Egrifta (tesamorelin), covering interaction mechanisms, safety, monitoring, and dosing guidance for HIV-associated lipodystrophy patients.
Can I Take Zinc With Egrifta (Tesamorelin)? Interaction Risk, Dosing, and Monitoring
Evidence-based guide on combining zinc supplements with tesamorelin (Egrifta). Covers pharmacokinetic and pharmacodynamic profiles, dose-separation strategy, copper balance risks, and clinical monitoring.